Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Joint AHPPI and ICR Meeting

5
July 2007

View Article

Accreditation of Phase I units in the UK

15
May 2007

View Article

Improving Safety in Phase I Trials - Planning Your Early Phase Development?

24
April 2007

View Article

Safety and Risk Management in Translational Medicine

3
March 2007

View Article

Calling all Clinical Phase I Outsourcing Professionals!

4
February 2007

View Article

Clinical Trials A Practical Guide to Design, Analysis & Reporting.

23
January 2007

View Article

Latest news

Latest article from our Director of Regulatory Strategy

April 10, 2026
We’re pleased to share the latest article from our Director of Regulatory Strategy, Dr Lisa Campbell
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event